TY  - JOUR

T1  - The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation.

JO  - Transpl Int

PY  - 2002/12/01

AU  - Chilcott JB

AU  - Holmes MW

AU  - Walters S

AU  - Akehurst RL

AU  - Nashan B

ED  - 

DO  - DOI: 10.1007/s00147-002-0458-1

VL  - 15

IS  - 9-10

SP  - 486

EP  - 493

Y2  - 2024/12/22

ER  -